Literature DB >> 12005333

Cross-reactivity in flavivirus serology: new implications of an old finding?

R Allwinn1, H W Doerr, P Emmerich, H Schmitz, W Preiser.   

Abstract

To investigate the influence of pre-existing antibodies against tick-borne encephalitis (TBE) or yellow fever (YF) viruses on dengue virus antibody test results, we examined sera from vaccinees and from individuals with previous TBE virus infection. Distinct IgG antibody cross-reactivity was found in about 15.1% in the YF-vaccinated group and in about 9.5% in the TBE-vaccinated group. Altogether 15 out of a total of 80 samples tested (18.8%) had detectable dengue virus IgG antibody titres. The serum samples from patients with acute TBE virus infection not only had the highest anti-TBE virus antibodies but were also highly cross-reactive against dengue virus antigens. The high cross-reactivity rate of YF and TBE antibody-positive sera in dengue virus antibody assays should be taken into account in the interpretation of laboratory tests for the diagnosis of flavivirus infections and when undertaking seroepidemiological surveys.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005333     DOI: 10.1007/s00430-001-0107-9

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  33 in total

1.  Psychiatric manifestations as the leading symptom in an expatriate with dengue fever.

Authors:  J A Blum; S Pfeifer; C F Hatz
Journal:  Infection       Date:  2010-06-22       Impact factor: 3.553

2.  Use of four dengue virus antigens for determination of dengue immune status by enzyme-linked immunosorbent assay of immunoglobulin G avidity.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Significant increase in travel-associated dengue fever in Germany.

Authors:  Regina Allwinn
Journal:  Med Microbiol Immunol       Date:  2011-02-11       Impact factor: 3.402

5.  Optimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay.

Authors:  Karla M Marrero-Santos; Manuela Beltrán; Jessica Carrión-Lebrón; Carolina Sanchez-Vegas; Davidson H Hamer; Elizabeth D Barnett; Luis M Santiago; Elizabeth A Hunsperger
Journal:  Clin Vaccine Immunol       Date:  2013-01-09

Review 6.  Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat.

Authors:  Jesse J Waggoner; Alejandra Rojas; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

7.  Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.

Authors:  Kerrie Vaughan; Jason Greenbaum; Martin Blythe; Bjoern Peters; Alessandro Sette
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

8.  Factors influencing dengue virus isolation by C6/36 cell culture and mosquito inoculation of nested PCR-positive clinical samples.

Authors:  Richard G Jarman; Ananda Nisalak; Kathryn B Anderson; Chonticha Klungthong; Butsaya Thaisomboonsuk; Winai Kaneechit; Siripen Kalayanarooj; Robert V Gibbons
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

9.  Dengue Virus Seroconversion in Travelers to Dengue-Endemic Areas.

Authors:  Rosemary M Olivero; Davidson H Hamer; William B MacLeod; Christine M Benoit; Carolina Sanchez-Vegas; Emily S Jentes; Lin H Chen; Mary E Wilson; Nina Marano; Emad A Yanni; Winnie W Ooi; Adolf W Karchmer; Laura Kogelman; Elizabeth D Barnett
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

10.  Concurrent dengue and malaria in Cayenne Hospital, French Guiana.

Authors:  Bernard Carme; Severine Matheus; Gerd Donutil; Olivia Raulin; Mathieu Nacher; Jacques Morvan
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.